
Last updated: 3 months ago
Arbutus Biopharma's 8-K Report: Key Updates for Investors on February 24, 2025
Discover crucial insights from Arbutus Biopharma Corporation's Form 8-K filing detailing significant events affecting ABUS stock. Stay informed about recent developments!